Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma
Clinical trial NCT04911621 · COMPLETED
Trial details
- NCT number
- NCT04911621
- Sponsor
- University Hospital, Antwerp
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2025-08-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.